| [1] | GARCIA-MONCO JC, CORTINA IE, FERREIRA E, et al. Reversible splenial lesion syndrome(RESLES): what's in a name?[J]. J Neuroimaging, 2011, 21(2): E1. doi: 10.1111/j.1552-6569.2008.00279.x |
| [2] | TADA H, TAKANASHI J, BARKOVICH AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lension[J]. Neurology, 2004, 63: 1854. doi: 10.1212/01.WNL.0000144274.12174.CB |
| [3] | AKSU B, KURTCAN S, ALKAN A, et al. Reversible corpus callosum splenial lesion due to steroid therapy[J]. J Neuroimaging, 2015, 25(3): 501. doi: 10.1111/jon.12128 |
| [4] | BULAKBASI N, KOCAOGLU M, TAYFUN C, et al. Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy[J]. AJNR Am J Neuroradiol, 2006, 27: 1983. |
| [5] | AL-EDRUS SA, NORZAINI R, CHUA R, et al. Reversible splenial lesion syndrome in neuroleptic malignant syndrome[J]. Biomed Imaging Interv J, 2009, 5(4): e24. |
| [6] | TAKANASHI J. Two newly proposed infectious encephalitis/encephalopathy syndromes[J]. Brain Dev, 2009, 31(7): 521. doi: 10.1016/j.braindev.2009.02.012 |
| [7] | AHUJA N, PALANICHAMY N, MACKIN P, et al. Olanzapineinduced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature[J]. J Psychopharmacol, 2010, 24: 125. doi: 10.1177/0269881108096901 |
| [8] | MAEDA M, TSUKAHARA H, TERADA H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions[J]. J Neuroradiol, 2006, 33(4): 229. doi: 10.1016/S0150-9861(06)77268-6 |
| [9] | TAKANASHI J, TADA H, MAEDA M, et al. Encephalopathy with a reversible splenial lesion is associated with hyponatremia[J]. Brain Dev, 2009, 31: 217. doi: 10.1016/j.braindev.2008.04.002 |
| [10] | SUN D, CHEN WH, BARALS S, et al. Mild encephalopathy/encephalitis with a reversible(MERS): a report of five neonatal cases[J]. J Huazhong Univ Sci Technolog Med Sci, 2017, 37(3): 433. doi: 10.1007/s11596-017-1753-5 |
| [11] | KIM JH, CHOI JY, KOH SB, et al. Reversible splenial abnormality in hypoglycemic encephalopathy[J]. Neuroradiology, 2007, 49: 217. doi: 10.1007/s00234-006-0184-y |
| [12] | KAINO K, KUMAGAI R, FURUKAWA S, et al. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine[J]. J Diabetes Investig, 2017, 8: 392. doi: 10.1111/jdi.12597 |